However, PD-L1 expression on TIICs might be more meaningful in terms of predictive value in specific tumors18 and response to immunotherapy.8,13 However, differences in molecular characteristics, including PD-L1 expression in the tumor microenvironment, might differ between types of cancers.29–31. This evidence concerns the gene CD274 and cancer.